502 related articles for article (PubMed ID: 28685150)
1. Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.
Coyle KM; Boudreau JE; Marcato P
Biomed Res Int; 2017; 2017():9620870. PubMed ID: 28685150
[TBL] [Abstract][Full Text] [Related]
2. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
Yeang CH; Beckman RA
Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
[TBL] [Abstract][Full Text] [Related]
3. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
4. Precision medicine driven by cancer systems biology.
Filipp FV
Cancer Metastasis Rev; 2017 Mar; 36(1):91-108. PubMed ID: 28265786
[TBL] [Abstract][Full Text] [Related]
5. Conquering the challenges of genotypic and phenotypic tumor heterogeneity to realize the promise of personalized cancer therapy: the role of academia.
Merajver S; Phadke S; Soellner M
Trans Am Clin Climatol Assoc; 2017; 128():169-179. PubMed ID: 28790501
[TBL] [Abstract][Full Text] [Related]
6. Cancer Systems Biology: a peek into the future of patient care?
Werner HM; Mills GB; Ram PT
Nat Rev Clin Oncol; 2014 Mar; 11(3):167-76. PubMed ID: 24492837
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome modeling and phenotypic assays for cancer precision medicine.
Jeong E; Moon SU; Song M; Yoon S
Arch Pharm Res; 2017 Aug; 40(8):906-914. PubMed ID: 28766239
[TBL] [Abstract][Full Text] [Related]
8. New insights from the widening homogeneity perspective to target intratumor heterogeneity.
Tong M; Deng Z; Zhang X; He B; Yang M; Cheng W; Liu Q
Cancer Commun (Lond); 2018 May; 38(1):17. PubMed ID: 29764517
[TBL] [Abstract][Full Text] [Related]
9. Genetic mutations in epigenetic modifiers as therapeutic targets in acute myeloid leukemia.
Nebbioso A; Benedetti R; Conte M; Iside C; Altucci L
Expert Opin Ther Targets; 2015; 19(9):1187-202. PubMed ID: 26028314
[TBL] [Abstract][Full Text] [Related]
10. Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis GJ; Coleman WB
J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S60-S66. PubMed ID: 28921651
[TBL] [Abstract][Full Text] [Related]
11. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
12. Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy.
Wu D; Wang DC; Cheng Y; Qian M; Zhang M; Shen Q; Wang X
Semin Cancer Biol; 2017 Feb; 42():13-19. PubMed ID: 27840278
[TBL] [Abstract][Full Text] [Related]
13. Cancer Precision Medicine: Why More Is More and DNA Is Not Enough.
Schütte M; Ogilvie LA; Rieke DT; Lange BMH; Yaspo ML; Lehrach H
Public Health Genomics; 2017; 20(2):70-80. PubMed ID: 28595192
[TBL] [Abstract][Full Text] [Related]
14. Defining precision: The precision medicine initiative trials NCI-MPACT and NCI-MATCH.
Coyne GO; Takebe N; Chen AP
Curr Probl Cancer; 2017; 41(3):182-193. PubMed ID: 28372823
[TBL] [Abstract][Full Text] [Related]
15. Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations.
Smith N; Nucera C
J Clin Endocrinol Metab; 2015 Jan; 100(1):35-42. PubMed ID: 25347569
[TBL] [Abstract][Full Text] [Related]
16. Network-based cancer precision medicine: A new emerging paradigm.
Tan A; Huang H; Zhang P; Li S
Cancer Lett; 2019 Aug; 458():39-45. PubMed ID: 31125640
[TBL] [Abstract][Full Text] [Related]
17. Clinical tumor sequencing: opportunities and challenges for precision cancer medicine.
Damodaran S; Berger MF; Roychowdhury S
Am Soc Clin Oncol Educ Book; 2015; ():e175-82. PubMed ID: 25993170
[TBL] [Abstract][Full Text] [Related]
18. Precision Medicine in Pediatric Oncology: Translating Genomic Discoveries into Optimized Therapies.
Tran TH; Shah AT; Loh ML
Clin Cancer Res; 2017 Sep; 23(18):5329-5338. PubMed ID: 28600472
[TBL] [Abstract][Full Text] [Related]
19. The challenge of intratumour heterogeneity in precision medicine.
Seoane J; De Mattos-Arruda L
J Intern Med; 2014 Jul; 276(1):41-51. PubMed ID: 24661605
[TBL] [Abstract][Full Text] [Related]
20. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
